Singapore markets closed

VRTX Jan 2023 165.000 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
70.800.00 (0.00%)
As of 10:51AM EDT. Market open.
Full screen
Previous close70.80
Open71.20
Bid91.60
Ask100.50
Strike165.00
Expiry date2023-01-20
Day's range70.80 - 71.20
Contract rangeN/A
Volume2
Open interest4
  • Motley Fool

    2 Top Biotech Stocks Defying the Bear Market

    Vertex Pharmaceuticals' shares have soared 24% year to date despite the macroeconomic headwinds in its way. The biotech owes that in part to its dominance in the market for drugs that treat the underlying causes of cystic fibrosis (CF), an area in which Vertex is the only game in town. Revenue and earnings continue to grow for Vertex thanks to its CF franchise.

  • Motley Fool

    Why Vertex Pharmaceuticals Stock Was Soaring Today

    An estimates-beating quarter and raised guidance were the elements pushing Vertex Pharmaceuticals (NASDAQ: VRTX) shares comfortably higher on Friday. After market hours on Thursday, Vertex published its second-quarter results. Vertex's growth was powered by its current blockbuster drug, Trikafta.

  • Motley Fool

    Vertex Pharmaceuticals (VRTX) Q2 2022 Earnings Call Transcript

    Image source: The Motley Fool. Vertex Pharmaceuticals (NASDAQ: VRTX)Q2 2022 Earnings CallAug 04, 2022, 4:30 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGood day, and welcome to the Vertex Pharmaceuticals second quarter 2022 earnings call.